Reminyl 16 mg capsulas duras de liberacion prolongada

Label: information for the user

Reminyl 16mg prolonged-release capsules

galantamine

Read this label carefully before starting to take this medicine, as it contains important information for you.

• Keep this label, as you may need to read it again.
• If you have any doubts, consult your doctor or pharmacist.
• This medicine has been prescribed only for you, and you must not give it to others even if they have the same symptoms as you, as it may harm them.
• If you experience any adverse effects, consult your doctor or pharmacist, even if they are not listed in this label. See section4

Label content:

1. What Reminyl is and for what it is used
2. What you need to know before starting to take Reminyl
3. How to take Reminyl
4. Possible adverse effects
5. Storage of Reminyl
6. Contents of the package and additional information

Reminyl contains the active ingredient “galantamine”, an anti-dementia medication. It is used in adults to treat the symptoms of mild to moderately severe Alzheimer's disease, a type of dementia that alters brain function.

Alzheimer's disease causes an increase in memory loss, confusion, and changes in behavior, making it increasingly difficult to perform routine daily activities.

It is thought that these effects are caused by a lack of “acetylcholine”, a substance responsible for transmitting messages between brain cells. Reminyl increases the amount of acetylcholine in the brain and thereby treats the symptoms of the disease.

The capsules are in the form of “prolonged release”.This means that they release the medication gradually.

Do not take Reminyl

• if you are allergic to galantamine or any of the other ingredients in this medication (listed in section6).
• if you have a severe liver or kidney disease.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Reminyl. This medication should only be used for Alzheimer's disease and is not recommended for other types of memory loss or confusion.

Severe side effects

Reminyl may cause severe skin reactions, heart problems, and seizures. You should be aware of these side effects while taking Reminyl. See section4 “Be aware of severe side effects”.

Before starting treatment with Reminyl, your doctor must know if you have or have had any of the following conditions:

• liver or kidney problems
• a heart condition (such as chest pain caused by physical activity, heart attack, heart failure, slow or irregular heartbeat, prolonged QTc interval)
• electrolyte level changes (natural substances in the blood, such as potassium)
• peptic ulcer (stomach)
• obstruction in the stomach or intestine
• a nervous system disorder (such as epilepsy or difficulty controlling body or limb movements (extrapyramidal disorder))
• a respiratory disease or infection that affects breathing (such as asthma, chronic obstructive pulmonary disease, or pneumonia)
• urinary retention problems.

Your doctor will decide if Reminyl is suitable for you or if the dose needs to be changed.

Also, inform your doctor if you have recently had surgeryin the stomach, intestine, or bladder. Your doctor will decide if Reminyl is suitable for you.

Reminyl may cause weight loss.Your doctor will check your weight regularly while you are taking Reminyl.

Children and adolescents

Reminyl is not recommended for use in children or adolescents.

Other medications and Reminyl

Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication.

Reminyl should not be taken with medications that work in the same way. These include:

• donepezil or rivastigmine (for Alzheimer's disease)
• ambenonium, neostigmine, or pyridostigmine (for severe muscle weakness)
• pilocarpine (taken orally for dry eyes or mouth).

Some medications may cause side effects more likely in people taking Reminyl. These include:

• medications that affect the QTc interval
• paroxetine or fluoxetine (antidepressants)
• quinidine (for irregular heartbeat)
• ketoconazole (an antifungal)
• erythromycin (an antibiotic)
• ritonavir (for HIV)

• nonsteroidal anti-inflammatory analgesics (such as ibuprofen), which may increase the risk of ulcers
• medications for certain heart conditions or high blood pressure (such as digoxin, amiodarone, atropine, beta blockers, or calcium channel blockers).If you take medications due to irregular heartbeat, your doctor may examine your heart using an electrocardiogram (ECG).

If you are taking any of these medications, your doctor may give you a lower dose of Reminyl.

Reminyl may affect some anesthetics. If you are undergoing general anesthesia, inform your doctor, in advance, that you are taking Reminyl.

Consult your doctor or pharmacist if you have any doubts.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.

Do not breastfeed while taking Reminyl.

Driving and operating machinery

Reminyl may make you feel dizzy or drowsy, especially during the first few weeks of treatment. If Reminyl affects you, do not drive or operate tools or machinery.

Reminyl contains saccharose

If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.

Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

If you are taking Reminyl tablets or oral solution and your doctor has told you that he will switch you to Reminyl prolonged-release capsules, read carefully the instructions that appear in “Switching from Reminyl tablets or oral solution to Reminyl prolonged-release capsules” in this section.

How much to take

You will start treatment with Reminyl at a low dose. The usual initial dose is 8 mg, taken once a day. Your doctor will gradually increase your dose, every 4 weeks or more, until you reach the most suitable dose for you. The maximum dose is 24 mg, taken once a day.

Your doctor will explain which dose you should start with and when to increase it.

If you are unsure of what to do or find that the effect of Reminyl is too strong or too weak, inform your doctor or pharmacist.

Your doctor needs to see you regularly to check that this medication is working and to discuss with you how you feel.

If you have liver or kidney problems,your doctor may give you a reduced dose of Reminyl or decide that this medication is not suitable for you.

Switching from Reminyl tablets or oral solution to Reminyl prolonged-release capsules

If you are currently taking Reminyl tablets or oral solution, your doctor may decide to switch you to Reminyl prolonged-release capsules. If this applies to you:

• Take the last dose of Reminyl tablets or oral solution at night
• The next morning, take your first dose of Reminyl prolonged-release capsules.

DO NOT take more than one capsule in a day. While taking a daily capsule of Reminyl prolonged-release, DO NOT take Reminyl tablets or oral solution.

How to take it

Reminyl capsules should be swallowed whole and NOT chewed or crushed. Take your dose of Reminyl once a day in the morning, with water or other liquids. Try to take Reminyl with food.

Drink plenty of liquid while taking Reminyl to stay hydrated.

If you take more Reminyl than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or

call the Toxicological Information Service, phone: 91 562 04 20 indicating the medication and the

amount ingested. Carry the packaging with the remaining capsules with you. Signs of an overdose may include:

• intense nausea and vomiting
• muscle weakness, slow heart rate, convulsions, and loss of consciousness.

If you forget to take Reminyl

If you forget to take a dose, leave that dose and continue treatment as usual with the next scheduled dose.Do not take a double dose to compensate for missed doses.

If you forget to take more than one dose, consult your doctor.

If you interrupt treatment with Reminyl

Consult your doctor before interrupting treatment with Reminyl. It is essential to continue takingthis medication to treat your disease.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

Like all medicines, this medicine can cause side effects, although not everyone will experience them.

Be aware of severe side effects

Stop taking Reminyl and consult a doctor or go to the nearest emergency service immediatelyif you notice any of the following side effects:

Skin reactions,including:

• Severe rash with blisters and skin peeling, especially around the mouth, nose, eyes, and genitals (Stevens-Johnson syndrome).
• Red rash covered with small, pus-filled bumps that can spread throughout the body, sometimes with fever (acute generalized exanthematous pustulosis).
• Rash that can cause blisters, with spots that look like small targets.

These skin reactions are rare in people taking Reminyl (they can affect up to 1 in 1,000 people).

Heart problemsincluding changes in heart rhythm (such as slow heartbeat or extra beats) or palpitations (feeling a rapid or irregular heartbeat). Heart problems can be seen as an abnormal tracing on an electrocardiogram (ECG), and may be common in people taking Reminyl (they can affect up to 1 in 10people).

Seizures. This is rare in people taking Reminyl (they can affect up to 1 in 100people).

You should stop taking Reminyl and seek help immediatelyif you notice any of the mentioned side effects.

Other side effects

Frequent side effects(they canaffect more than 1 in 10people):

• Nausea and vomiting. These side effects are more likely to occur in the first weeks of treatment or when the dose is increased. They usually disappear gradually as the body adapts to the medicine and generally only last for a few days. If you experience these side effects, your doctor may recommend drinking more liquids and may prescribe a medication to help you feel better.

Frequent side effects(they canaffectup to 1 in 10people):

• Loss of appetite, weight loss
• Seeing, feeling, or hearing things that are not there (hallucinations)
• Depression
• Dizziness or fainting
• Trembling or muscle spasms
• Headache
• Feeling very tired, weak, or generally unwell
• Feeling extremely sleepy and having little energy
• Increased blood pressure
• Abdominal pain or discomfort
• Diarrhea
• Indigestion
• Falls
• Wounds

Infrequent side effects(they canaffect up to 1 in 100people):

• Allergic reaction
• Insufficient water in the body (dehydration)
• Prickling or numbness of the skin
• Change in sense of taste
• Daytime drowsiness
• Difficulty controlling body or limb movements (extrapyramidal disorder)
• Blurred vision
• Tinnitus (persistent ringing in the ears)
• Low blood pressure
• Flushing
• Nausea (retching)
• Excessive sweating
• Muscle weakness
• Increased liver enzymes in the blood.

Rare side effects(they canaffect up to 1 in 1,000people):

• Inflamed liver (hepatitis).

Reporting side effects

If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet.You can also report them directly through theSpanish System for Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es/. By reporting side effects, you can contribute to providing more information on the safety of this medicine.

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the label after CAD. The expiration date is the last day of the month indicated.

Do not store at a temperature above30°C.

Medicines should not be disposed of through drains or in the trash.Deposit containers and medications that you no longer need at theSIGREpoint of the pharmacy.Ask your pharmacist how to dispose of containers and medications that you no longer need. This will help protect the environment.

Composition of Reminyl

• The active ingredient is galantamine. Each prolonged-release capsule contains 16mg of galantamine (as hydrobromide).
• The other components are:

Dietlyl phthalate, ethylcellulose, hypromellose, macrogol 400, cornstarch, sucrose, gelatin, titanium dioxide (E171), iron oxide black (E172), shellac, and propylene glycol (E1520), iron oxide red (E172)

Appearance of the product and contents of the package

Reminyl 16mg capsules are pink with the inscription “G16”. Each package contains blisters of 7, 28, 56 or 84 capsules or bottles of 300capsules.

Only some package sizes may be marketed.

Holder of the marketing authorization and responsible for manufacturing

Holder of the marketing authorization

Essential Pharma Limited,

Vision Exchange Building,

Triq it-Territorjals, Zone 1,

Central Business District,

Birkirkara, CBD 1070,

Malta

Responsible for manufacturing

Janssen-Cilag, SpA

Via C. Janssen

04100 Borgo San Michele

Latina (Italy)

This medicine is authorized in the Member States of the European Union with the following names:

AustriaReminyl 16mg Retardkapseln

BelgiumReminyl 16mg hard capsules with prolonged release

DenmarkReminyl 16mg depot capsules, hard

FinlandReminyl 16mg depot capsule, hard

GreeceReminyl16mgcapsules with prolonged release, hard

IrelandReminyl XL 16mg prolonged release capsules

ItalyReminyl16mg hard capsules with prolonged release

LuxembourgReminyl 16mg hard capsules with prolonged release

NorwayReminyl 16mg depot capsules, hard

PortugalReminyl 16mg prolonged-release capsules

SpainReminyl 16mg hard capsules with prolonged release

SwedenReminyl 16mg depot capsules, hard

United Kingdom (Northern Ireland)Reminyl XL 16 mg prolonged release capsules

This leaflet has been approved in:October 2021.

The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) (http://www.aemps.gob.es/).